1. Home
  2. CALM vs CPRX Comparison

CALM vs CPRX Comparison

Compare CALM & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cal-Maine Foods Inc.

CALM

Cal-Maine Foods Inc.

HOLD

Current Price

$75.28

Market Cap

3.7B

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.30

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALM
CPRX
Founded
1957
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.4B
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
CALM
CPRX
Price
$75.28
$31.30
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$92.00
$35.00
AVG Volume (30 Days)
659.0K
2.9M
Earning Date
04-01-2026
05-11-2026
Dividend Yield
11.13%
N/A
EPS Growth
338.49
28.24
EPS
7.34
0.50
Revenue
$1,351,609,000.00
$119,072,803.00
Revenue This Year
N/A
$9.20
Revenue Next Year
N/A
$10.51
P/E Ratio
$10.41
$62.58
Revenue Growth
N/A
16.39
52 Week Low
$71.92
$19.05
52 Week High
$126.40
$32.56

Technical Indicators

Market Signals
Indicator
CALM
CPRX
Relative Strength Index (RSI) 43.94 72.86
Support Level $72.83 $31.00
Resistance Level $79.75 $31.33
Average True Range (ATR) 2.34 0.08
MACD -0.09 -0.19
Stochastic Oscillator 27.23 81.94

Price Performance

Historical Comparison
CALM
CPRX

About CALM Cal-Maine Foods Inc.

Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: